
浏览全部资源
扫码关注微信
1.沧州市中心医院脑血管病二科,河北 沧州061000
2.沧州市中心医院放射介入科,河北 沧州061000
3.沧州市中心医院科研处,河北 沧州061000
李阔,E-mail:pxxxhb@163.com
收稿:2025-02-25,
纸质出版:2025-12-25
移动端阅览
李阔,王丽轩,张传锁等.急性分水岭脑梗死血清KLF4、OLFM-2水平及其与血管内支架植入术后再狭窄的关系[J].局解手术学杂志,2025,34(12):1091-1095.
.Serum KLF4 and OLFM-2 levels in acute cerebral watershed infarction and their relationship with in-stent restenosis after endovascular stent implantation[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2025,34(12):1091-1095.
李阔,王丽轩,张传锁等.急性分水岭脑梗死血清KLF4、OLFM-2水平及其与血管内支架植入术后再狭窄的关系[J].局解手术学杂志,2025,34(12):1091-1095. DOI: 10.11659/jjssx.02E025127.
.Serum KLF4 and OLFM-2 levels in acute cerebral watershed infarction and their relationship with in-stent restenosis after endovascular stent implantation[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2025,34(12):1091-1095. DOI: 10.11659/jjssx.02E025127.
目的
2
探讨急性分水岭脑梗死(ACWI)患者血清锌指样转录因子4(KLF4)、嗅素蛋白-2(OLFM-2)水平及其与血管内支架植入术后支架内再狭窄(ISR)的关系。
方法
2
选取2023年1月至2024年1月本院收治的187例ACWI患者作为研究对象(ACWI组),其中根据ISR发作情况将患者分为ISR组(75例)、非ISR组(112例)。另随机选取同期在本院体检中心检查的150例健康体检者作为对照组。比较ACWI组患者与对照组受试者、ISR组与非ISR组患者的临床资料及血清KLF4、OLFM-2水平。多因素
Logistic
回归分析影响ACWI患者血管内支架植入术后发生ISR的相关因素。受试者工作特征(
ROC
)曲线分析血清KLF4、OLFM-2对ACWI患者血管内支架植入术后发生ISR的预测价值。
结果
2
ACWI组患者血清KLF4水平低于对照组(
P
<
0.05),OLFM-2水平高于对照组(
P
<
0.05)。ISR组患者血清KLF4水平低于非ISR组,OLFM-2水平、术前NIHSS评分、LDL-C水平高
于非ISR组(
P
<
0.05)。多因素
Logistic
回归分析显示,校正术前NIHSS评分后,KLF4是ACWI患者血管内支架植入术后发生ISR的保护因素(
P
<
0.05),OLFM-2是ACWI患者血管内支架植入术后发生ISR的危险因素(
P
<
0.05)。血清KLF4、OLFM-2单独及联合预测ACWI患者血管内支架植入术后发生ISR的曲线下面积(
AUC
)分别为0.827、0.786、0.893,二者联合预测的
AUC
优于KLF4、OLFM-2单独预测(
Z
KLF4
=3.236、
Z
OLFM-2
=3.713,
P
<
0.05)。
结论
2
ACWI患者血管内支架植入术后血清KLF4水平降低,OLFM-2水平升高,与术后ISR发生相关。
Objective
2
To investigate the serum levels of kruppel-like factor 4 (KLF4) and olfactomedin-like 2 (OLFM-2) in patients with acute cerebral watershed infarction (ACWI) and their relationship with in-stent restenosis (ISR) after endovascular stent implantation.
Methods
2
A total of 187 ACWI patients admitted to our hospital from January 2023 to January 2024 were selected as the study subjects (the ACWI group). Among them, the patients were divided into the ISR group (75 cases) and the non-ISR group (112 cases) according to the occurrence of ISR. Another 150 healthy individuals who underwent physical examinations at the physical examination center of our hospital during the same period were randomly selected as the control group. The clinical data and serum KLF4 and OLFM-2 levels between the ACWI group and the control group, and between the ISR group and the non-ISR group. Multivariate
Logistic
regression was used to analyze the related factors affecting the occurrence of ISR after endovascular stent implantation in ACWI patients.
Receiver operating characteristic
(
ROC
) curve was used to analyze the predictive value of serum KLF4 and OLFM-2 for the occurrence of ISR after endovascular stent implantation in ACWI patients.
Results
2
The serum KLF4 level of patients in the ACWI group was lower
than that in the control group (
P
<
0.05), and the OLFM-2 level was higher than that in the control group (
P
<
0.05). The serum KLF4 level of patients in the ISR group was lower than that in the non-ISR group, while the OLFM-2 level, preoperative NIHSS score, and LDL-C level were higher than those in the non-ISR group (
P
<
0.05). Multivariate
Logistic
regression analysis showed that after adjusting for preoperative NIHSS score,KLF4 was a protective factor for the occurrence of ISR after endovascular stent implantation in ACWI patients (
P
<
0.05), while OLFM-2 was a risk factor for the occurrence of ISR after endovascular stent implantation in ACWI patients (
P
<
0.05). The
areas under the curve
(
AUC
) of serum KLF4 and OLFM-2 alone and in combination for predicting ISR after endovascular stent implantation in ACWI patients were 0.827, 0.786, and 0.893, respectively. The
AUC
predicted by the combination of the two was better than that predicted by KLF4 and OLFM-2 alone (
Z
KLF4
=3.236,
Z
OLFM-2
=3.713,
P
<
0.05).
Conclusion
2
The serum KLF4 levels decrease and OLFM-2 levels increase after endovascular stent implantation in ACWI patients, which is associated with the occurrence of postoperative ISR.
Zhang P , Xu C , Liu Z , et al . Unleashing the therapeutic power of verteporfin-eluting stents:modulating YAP signaling to combat carotid artery restenosis and cerebral watershed infarction [J]. Mol Cell Biochem , 2024 , 22 ( 1 ): 1 - 6 . doi: 10.1007/s11010-024-05160-4 http://dx.doi.org/10.1007/s11010-024-05160-4 .
秦保健 , 李琳 , 唐荣盛 , 等 . 丁苯酞联合尤瑞克林对分水岭脑梗死急性期患者神经、血管内皮功能及血液流变学的影响 [J]. 中国急救复苏与灾害医学杂志 , 2022 , 17 ( 3 ): 353 - 356 . doi: 10.3969/j.issn.1673-6966.2022.03.019 http://dx.doi.org/10.3969/j.issn.1673-6966.2022.03.019
Zhang G , Zhu Y , Ling Y , et al . Endovascular treatment of acute ischemic stroke due to isolated proximal posterior artery occlusion [J]. Front Surg , 2022 , 9 ( 1 ): 919509 - 919513 . doi: 10.1136/jnis-2025-SNIS.14 http://dx.doi.org/10.1136/jnis-2025-SNIS.14 .
Giustino G , Colombo A , Camaj A , et al . Coronary in-stent restenosis:JACC state-of-the-art review [J]. J Am Coll Cardiol , 2022 , 80 ( 4 ): 348 - 372 . doi: 10.1016/j.jacc.2022.05.017 http://dx.doi.org/10.1016/j.jacc.2022.05.017 .
Jiang F , Zhang B , Zhang X , et al . miRNA‑92a inhibits vascular smooth muscle cell phenotypic modulation and may help prevent in‑stent restenosis [J]. Mol Med Rep , 2023 , 27 ( 2 ): 40 - 48 . doi: 10.3892/mmr.2023.12927 http://dx.doi.org/10.3892/mmr.2023.12927 .
卫飞鹏 , 王国壮 . 血清OLFM-2、ET-1、sTREM-1预测下肢动脉硬化闭塞症患者支架植入术后血管再发狭窄的价值研究 [J]. 国际检验医学杂志 , 2024 , 45 ( 15 ): 1844 - 1848 . doi: 10.3969/j.issn.1673-4130.2024.15.010 http://dx.doi.org/10.3969/j.issn.1673-4130.2024.15.010 .
中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组 . 中国急性缺血性脑卒中诊治指南2010 [J]. 中华神经科杂志 , 2010 , 43 ( 2 ): 146 - 153 . doi: 10.3969/j.issn.1007-9572.2011.35.004 http://dx.doi.org/10.3969/j.issn.1007-9572.2011.35.004 .
Chalos V , van der Ende NAM , Lingsma HF , et al . National institutes of health dtroke scale:an alternative primary outcome measure for trials of acute treatment for ischemic stroke [J]. Stroke , 2020 , 51 ( 1 ): 282 - 290 . doi: 10.1161/STROKEAHA.119.026791 http://dx.doi.org/10.1161/STROKEAHA.119.026791 .
Azova M , Timizheva K , Ait Aissa A , et al . Gene polymorphisms of the renin-angiotensin-aldosterone system as risk factors for the development of in-stent restenosis in patients with stable coronary artery disease [J]. Biomolecules , 2021 , 11 ( 5 ): 763 - 775 . doi: 10.3390/biom 11050763 http://dx.doi.org/10.3390/biom11050763 .
李致文 , 许英冬 , 魏玉清 . 颈动脉支架植入术后缺血性脑卒中患者脑组织灌注神经影像学及相关因子变化 [J]. 中国实用神经疾病杂志 , 2024 , 27 ( 7 ): 878 - 882 . doi: 10.12083/SYSJ.231329 http://dx.doi.org/10.12083/SYSJ.231329 .
Megaly M , Alani F , Cheng CI , et al . Risk factors for the development of carotid artery in-stent restenosis:multivariable analysis [J]. Cardiovasc Revasc Med , 2021 , 24 ( 1 ): 65 - 69 . doi: 10.1016/j.carrev. 2020.09.005 http://dx.doi.org/10.1016/j.carrev.2020.09.005 .
Ma H , Dong A . Dysregulation of lncRNA SNHG1/miR-145 axis affects the biological function of human carotid artery smooth muscle cells as a mechanism of carotid artery restenosis [J]. Exp Ther Med , 2021 , 21 ( 5 ): 423 - 431 . doi: 10.3892/etm.2021.9867 http://dx.doi.org/10.3892/etm.2021.9867 .
Chen R , McVey DG , Shen D , et al . Phenotypic switching of vascular smooth muscle cells in atherosclerosis [J]. J Am Heart Assoc , 2023 , 12 ( 20 ): e031121 - e031128 . doi: 10.1161/JAHA.123.031121 http://dx.doi.org/10.1161/JAHA.123.031121 .
Wang C , Li L . The critical role of KLF4 in regulating the activation of A1/A2 reactive astrocytes following ischemic stroke [J]. J Neuroinflammation , 2023 , 20 ( 1 ): 44 - 49 . doi: 10.1186/s12974-023-02742-9 http://dx.doi.org/10.1186/s12974-023-02742-9 .
Li K , Zhang C , Wang LX , et al . KLF4's role in regulating nitric oxide production and promoting microvascular formation following ischemic stroke [J]. Nitric Oxide , 2024 , 154 ( 1 ): 86 - 104 . doi: 10.1016/j.niox. 2024.11.004 http://dx.doi.org/10.1016/j.niox.2024.11.004 .
Wang QS , Xiao RJ , Peng J , et al . Bone marrow mesenchymal stem cell-derived exosomal KLF4 alleviated ischemic stroke through inhibiting N6-methyladenosine modification level of Drp1 by targeting lncRNA-ZFAS1 [J]. Mol Neurobiol , 2023 , 60 ( 7 ): 3945 - 3962 . doi: 10.1007/s12035-023-03301-2 http://dx.doi.org/10.1007/s12035-023-03301-2 .
Zhang X , Wang L , Han Z , et al . KLF4 alleviates cerebral vascular injury by ameliorating vascular endothelial inflammation and regulating tight junction protein expression following ischemic stroke [J]. J Neuroinflammation , 2020 , 17 ( 1 ): 107 - 113 . doi: 10.1186/s12974-020-01780-x http://dx.doi.org/10.1186/s12974-020-01780-x .
王武帅 , 胡陶 , 杨耀 , 等 . 薄荷醇对低压低氧诱导小鼠肺动脉高压的作用及机制研究 [J]. 中国药理学通报 , 2024 , 40 ( 1 ): 62 - 69 . doi: 10.12360/CPB202307069 http://dx.doi.org/10.12360/CPB202307069
艾合顺 , 孙忠东 , 任冠桦 , 等 . Krüppel样因子4基因修饰的间充质干细胞抑制颈动脉再狭窄的研究 [J]. 中华实验外科杂志 , 2024 , 41 ( 5 ): 929 - 931 . doi: 10.3760/cma.j.cn421213-20230905-01321 http://dx.doi.org/10.3760/cma.j.cn421213-20230905-01321 .
He L , Gao K , Liu H , et al . Smooth muscle cell-specific knockout of interferon gamma (IFN-γ) receptor attenuates intimal hyperplasia via STAT1-KLF4 activation [J]. Life Sci , 2021 , 25 ( 1 ): 119651 - 119658 . doi: 10.1016/j.lfs.2021.119651 http://dx.doi.org/10.1016/j.lfs.2021.119651 .
Bertran L , Jorba-Martin R , Barrientos-Riosalido A , et al . New insights of OLFM2 and OLFM4 in gut-liver axis and their potential involvement in nonalcoholic fatty liver disease [J]. Int J Mol Sci , 2022 , 23 ( 13 ): 7442 - 7448 . doi: 10.3390/ijms23137442 http://dx.doi.org/10.3390/ijms23137442 .
Tang Y , Liu Y , Wang X , et al . OLFM2 promotes epithelial-mesenchymal transition,migration,and invasion in colorectal cancer through the TGF-β/Smad signaling pathway [J]. BMC Cancer , 2024 , 24 ( 1 ): 204 - 211 . doi: 10.1186/s12885-024-11925-3 http://dx.doi.org/10.1186/s12885-024-11925-3 .
Li H , Gui H , Yuan G , et al . Increased plasma olfactomedin 2 after interventional therapy is a predictor for restenosis in lower extremity arteriosclerosis obliterans patients [J]. Scand J Clin Lab Invest , 2018 , 78 ( 4 ): 269 - 274 . doi: 10.1080/00365513.2018.1452287 http://dx.doi.org/10.1080/00365513.2018.1452287 .
Maguire EM , Xiao Q . Noncoding RNAs in vascular smooth muscle cell function and neointimal hyperplasia [J]. FEBS J , 2020 , 287 ( 24 ): 5260 - 5283 . doi: 10.1111/febs.15357 http://dx.doi.org/10.1111/febs.15357 .
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621